Communique from extra general meeting in Senzime AB (publ)
The extra general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) was held on 2 July 2020 in Uppsala by postal voting in advance whereby the shareholders primarily resolved on the following matters.Introduction of employee stock option program 2020/2023 The extra general meeting resolved, in accordance with the proposal of the board of directors, to introduce employee stock option program 2020/2023 through a directed issue of warrants to the Company’s wholly owned subsidiary MD Biomedical AB, corp.reg.no 556837-0273 (the ”Subsidiary”), in order to ensure the